• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PARI RESPIRATORY EQUIPMENT, INC. ALTERA HANDSET (NO COST) ; NEBULIZER (DIRECT PATIENT INTERFACE)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PARI RESPIRATORY EQUIPMENT, INC. ALTERA HANDSET (NO COST) ; NEBULIZER (DIRECT PATIENT INTERFACE) Back to Search Results
Device Problem Break (1069)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 01/01/2020
Event Type  malfunction  
Event Description
Pt uses the altera device to administer her cayston medication 75 mg three times a day for 2 weeks on and 2 weeks off.Ndc for cayston is 61958-0901-01.Pt stated the machine broke that she uses to initiate her cayston.No add'l info.Pt did not report any adverse events, unk if she missed any doses, has the device on hand for investigation or if she had a backup.New device shipped 03/03/2020.Product lot number and expiration date unk.Reported to (b)(6) by pt/caregiver.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALTERA HANDSET (NO COST)
Type of Device
NEBULIZER (DIRECT PATIENT INTERFACE)
Manufacturer (Section D)
PARI RESPIRATORY EQUIPMENT, INC.
MDR Report Key9853376
MDR Text Key184522816
Report NumberMW5093842
Device Sequence Number1
Product Code CAF
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/18/2020
Patient Sequence Number1
Patient Age62 YR
-
-